PharVision Advisers’s Ferrari RACE Stock Holding History

PharVision Advisers’s Portfolio RACE Stock Details RACE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-484	Closed	-$235K	–	949
2025 Q3	$235K	Buy	+484	New	+$232K	0.13%	376

Other funds holding RACE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Amundi Paris, France $413B AUM 44.57% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BOI

Bank of Italy Rome, Italy $2.2B AUM 1.53% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

PharVision Advisers's RACE Position: Q4 2025 in Review

PharVision Advisers sold out of Ferrari (RACE) in Q4 2025, closing a stake of 484 shares — an estimated $235K sold.

PharVision Advisers first reported a position in RACE in Q3 2025 and held it in 1 quarter. The position peaked at $235K in Q3 2025. 769 funds tracked by Wall St. Rank hold RACE as of Q4 2025.

PharVision Advisers reported no remaining Ferrari position as of Q4 2025 after selling out during the quarter.
PharVision Advisers sold 484 Ferrari shares in Q4 2025, an estimated $235K.
PharVision Advisers first reported a position in Ferrari in Q3 2025 and held it in 1 quarter.
PharVision Advisers's Ferrari position peaked at $235K in Q3 2025.
769 funds tracked by Wall St. Rank held Ferrari as of Q4 2025.

Based on PharVision Advisers's 13F filing for Q4 2025, filed 17 Feb 2026.